Galera Therapeutics (GRTX)
US Market

Galera Therapeutics (GRTX) Stock Price & Analysis


GRTX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.12 - $3.50
Previous Close$3.04
Average Volume (3M)690.32K
Market Cap
Enterprise Value$82.69M
Total Cash (Recent Filing)$47.75M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.4
Aug 14, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.22
Shares Outstanding42,906,833
10 Day Avg. Volume696,742
30 Day Avg. Volume690,323
Standard Deviation0.47
Financial Highlights & Ratios
Price to Book (P/B)-1.14
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.60
Price Target Upside264.24% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Galera Therapeutics’s price range in the past 12 months?
Galera Therapeutics lowest stock price was $1.12 and its highest was $3.50 in the past 12 months.
    What is Galera Therapeutics’s market cap?
    Currently, no data Available
    When is Galera Therapeutics’s upcoming earnings report date?
    Galera Therapeutics’s upcoming earnings report date is Aug 14, 2023 which is in 76 days.
      How were Galera Therapeutics’s earnings last quarter?
      Galera Therapeutics released its earnings results on May 11, 2023. The company reported -$0.5 earnings per share for the quarter, missing the consensus estimate of -$0.382 by -$0.118.
        Is Galera Therapeutics overvalued?
        According to Wall Street analysts Galera Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Galera Therapeutics pay dividends?
          Galera Therapeutics does not currently pay dividends.
          What is Galera Therapeutics’s EPS estimate?
          Galera Therapeutics’s EPS estimate is -$0.4.
            How many shares outstanding does Galera Therapeutics have?
            Galera Therapeutics has 42,906,834 shares outstanding.
              What happened to Galera Therapeutics’s price movement after its last earnings report?
              Galera Therapeutics reported an EPS of -$0.5 in its last earnings report, missing expectations of -$0.382. Following the earnings report the stock price went down -1.893%.
                Which hedge fund is a major shareholder of Galera Therapeutics?
                Among the largest hedge funds holding Galera Therapeutics’s share is Blackstone Inc.. It holds Galera Therapeutics’s shares valued at 4M.


                  Galera Therapeutics Stock Smart Score

                  The Galera Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Galera Therapeutics

                  Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.


                  Top 5 ETFs holding GRTX

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold GRTX. The ETFs are listed according to market value of GRTX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  TCR2 Therapeutics
                  Cidara Therapeutics
                  SELLAS Life Sciences Group
                  Biora Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis